Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Organon Shares Rise on Report of Sun Pharma Bid
Shares of Organon rose after The Economic Times reported that Sun Pharmaceutical Industries was set to proceed on a binding $12 billion bid for the healthcare company. The stock jumped 19% to $8.23 in premarket trading. Through Thursday's close, it…
Stock Movers: Lumentum, Sun Pharma, Porsche
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street. Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for…
Organon rises as Sun Pharma nears buyout deal (OGN:NYSE)
Organon (OGN) shares continued to climb on Friday, adding ~11% in the premarket after media reports from India indicated that Mumbai-based generic drugmaker Sun Pharmaceutical Industries had submitted a $12B binding offer for the U.S. company.
Insilico Medicine launches Pharma AI Spring Kickoff 2026 webinar
As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science. To explore these advancements, Insilico Medicine…
'Made in India': A fine exposition of the personal and professional in creating pharma brand Lupin
Is there any major Indian industry without the dominance of the Tatas, Birlas, Ambanis, and other large legacy business houses? Think of IT and automobiles, and you run into TCS and Tata Motors. If it is finance, you have the Bajajs. Take any of…
Raichur-based pharma firm wins two State safety awards
Raichur-based Shilpa Pharma Lifesciences Ltd. won two awards at the Karnataka State Level Safety Awards presentation during the National Safety Day celebrations at the NIMHANS Convention Centre in Bengaluru on Thursday. The event was organised by…
Sun Pharma shares down 4 per cent on reports of overtures for US-based Organon
Sun Pharmaceutical Industries' shares closed down almost 4 percent at ₹1,654.70 on BSE, following reports that the drugmaker was close to sealing a deal for US-based Organon, in a $12 billion deal, its biggest transaction yet. Known to be…
Urogen Pharma (NASDAQ:URGN) Shares Gap Up - Time to Buy?
Urogen Pharma (NASDAQ:URGN - Get Free Report) shares gapped up prior to trading on Friday. The stock had previously closed at $20.53, but opened at $21.40. Urogen Pharma shares last traded at $20.9650, with a volume of 93,817 shares changing hands.
HC Wainwright Decreases Earnings Estimates for Innate Pharma
Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA - Free Report) - Stock analysts at HC Wainwright decreased their FY2026 earnings per share (EPS) estimates for shares of Innate Pharma in a report released on Tuesday, April 7th. HC Wainwright analyst…
BridgeBio Pharma (NASDAQ:BBIO) Raised to 'Moderate Buy' at Royal Bank Of Canada
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) was upgraded by stock analysts at Royal Bank Of Canada to a 'moderate buy' rating in a note issued to investors on Wednesday, Zacks.com reports. BridgeBio's Volatile Week Puts Biotech Stocks Under a…
D-Street rebounds: Sensex, Nifty up 1%, auto stocks roar, Sun Pharma, Infosys, TCS top losers
Domestic equity benchmarks continued to trade in positive territory during the mid-trading session on Friday, as investors drew comfort from a fragile ceasefire between the US and Iran, easing near-term geopolitical concerns. Asian markets were…
Indian Stock Market Rebounds: Sensex Nifty Surge on Banking, Global Cues
Indian benchmark indices Sensex and Nifty surged over 1 per cent, propelled by robust buying in banking and financial counters and a positive global market sentiment, as investors anticipate progress in US-Iran negotiations. The Sensex surged…
Eli Lilly loses weight loss drug market share as generics flood India
March data tracked by industry intelligence provider Pharmarack show a five-percentage-point slide in Eli Lilly $LLY 's slice of India's GLP-1 weight-loss market, dropping from 61% to 56% as a wave of cheap semaglutide generics arrived following…
Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India
Eli Lilly's market share in India's weight‑loss drug market fell to 56% in March from 61% in February. Novo Nordisk's market share remained steady at 25%. Indian generic drugmakers have launched 26 brands of semaglutide that directly compete…
Nifty, Sensex rebound in early trade driven by rally in banking stocks, positive trend in global markets
Equity benchmark indices Sensex and Nifty rebounded in early trade on Friday (April 10, 2026), driven by a rally in bank stocks and a positive trend in global markets. The 30-share BSE Sensex jumped 630.08 points to 77,261.73 in early trade. The…
Receive a Daily briefing on Pharma Industry News
Get Started